Thermo Fisher sells its microbiology unit to Astorg for $1.075B, spinning it into an independent entity to drive growth and improve operations.Abstract: Thermo Fisher Scientific has agreed to sell its microbiology business to Astorg, a European private-equity firm, for $1.075 billion. The sale creates an independent microbiology unit focused on antimicrobial susceptibility testing and culture media. Astorg aims to accelerate growth and enhance operational performance through strategic autonomy, potentially benefiting customers and investors while Thermo Fisher exits a non-core asset.

NodeGuardian

2026-05-11 16:31:36

Abstract generation in progress

Thermo Fisher Scientific has announced the sale of its microbiology business to the European private equity firm Astorg for $1.075 billion. The unit, which generated $645 million in revenue in 2025, provides antimicrobial susceptibility testing and culture media solutions. This move will make the microbiology business an independent entity, with Astorg aiming to accelerate its growth and enhance operational performance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GateSquareMayTradingShare
1.26M Popularity
#
TROLLSurgesOver160PercentInTwoDays
8.55M Popularity
#
DailyPolymarketHotspot
908.08K Popularity
#
CapitalFlowsBackToAltcoins
23.22K Popularity
#
TrumpVisitsChinaMay13
25.87M Popularity

Sitemap

Thermo Fisher Scientific sells microbiology business for $1B to European private equity firm

Trending Topics

GateSquareMayTradingShare

TROLLSurgesOver160PercentInTwoDays

DailyPolymarketHotspot

CapitalFlowsBackToAltcoins

TrumpVisitsChinaMay13

Pin